Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) With Language Impairment Accompanied by Developmental Disability Caused by Forkhead Box Protein 1 (FOXP1) Exon Deletion: A Case Report
Shuliweeh Alenezi, Ahmed Alyahya, Hesham Aldhalaan, Shuliweeh Alenezi, Ahmed Alyahya, Hesham Aldhalaan
Abstract
Forkhead box protein 1 (FOXP1) (OMIM: 605515) is located at chromosomal region 3p14.1, which codes for a transcriptional repressor protein. FOXP1 syndrome (FOXP1S) (OMIM #613670) is caused by FOXP1 gene deletions and mutations (nonsense, missense, and in-frame deletions). It is identified by the presence of intellectual disability with language impairment, with or without autistic features. This paper describes the case of a seven-year-old girl mainly presenting with autism spectrum disorder, language impairment, and intellectual disability. In addition, she also exhibited signs of attention deficit hyperactivity disorder. Whole-exome sequencing showed that she had a mutation in the FOXP1 gene; the variant revealed was FOXP1: NM_001244813 with a deleted segment (1152-1164) of exon 11. Subsequently, she was diagnosed with FOXP1 syndrome. In order to manage behavioral disturbance, risperidone was given, and she showed marked improvement. In this article, we report the characteristic features of attention deficits hyperactivity in addition to previously reported autism spectrum disorder with language impairment accompanied by intellectual disability caused by FOXP1 exon deletion. This study aims to provide a systematic, comprehensive presentation of a patient with a FOXP1 mutation to contribute to the existing literature on this subject.
Keywords: adhd; asd; case report; developmental disability; foxp1; genetic expression.
Conflict of interest statement
The authors have declared that no competing interests exist.
Copyright © 2021, Alenezi et al.
References
- FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring. Lozano R., Gbekie C., Siper PM., et al. J Neurodev Disord 13. 2021;18:13.
- Autism with dysphasia accompanied by mental retardation caused by FOXP1 exon deletion: a case report. Lin SZ, Zhou XY, Wang WQ, Jiang K. World J Clin Cases. 2021;9:6858–6866.
- Individuals with FOXP1 syndrome present with a complex neurobehavioral profile with high rates of ADHD, anxiety, repetitive behaviors, and sensory symptoms. Trelles MP, Levy T, Lerman B, et al. Mole Aut . 2021;12:61.
- Novel FOXP1 pathogenic variants in two Indian subjects with syndromic intellectual disability. Moirangthem A, Phadke SR. Am J Med Genet A. 2021;185:1324–1327.
- Peruvian newborn male with 3p13 deletion syndrome encompassing the FOXP1 gene: review of the literature. Abarca-Barriga HH, Trubnykova M, Chavesta-Velásquez F, Barletta-Carrillo C, Ordoñez-Linares M, Rondón-Abuhadba A. J Pediatr Genet. 2020;9:270–278.
- Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth. Pringsheim T, Panagiotopoulos C, Davidson J, Ho J. J Can Acad Child Adolesc Psychiatry. 2011;20:218–233.
- Digital health interventions (DHI) for the treatment of attention deficit hyperactivity disorder (ADHD) in children - a comparative review of literature among various treatment and DHI. Pandian GS, Jain A, Raza Q, Sahu KK. Psychiatry Res. 2021;297:113742.
Source: PubMed